Use of a force-plate actometer for detecting and quantifying vertical leaping induced by amphetamine in BALB/cJ mice, but not in C57BL/6J, DBA/2J, 129X1/SvJ, C3H/HeJ, and CD-1 mice

Journal of Neuroscience Methods

Volumn 153, Issue 1, 2006, Pages 48-54

  McKerchar, Todd L ^a   Zarcone, Troy J ^b   Fowler, Stephen C ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Amphetamine induced leaping; Jumping; Low mobility; Mice; Popping; Sensitization; Spatial confinement

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; JUMPING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIZATION; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; BIOMECHANICS; C3H MOUSE; C57BL MOUSE; COMPARATIVE STUDY; DBA MOUSE; DRUG EFFECT; EQUIPMENT; EQUIPMENT DESIGN; EVALUATION; INSTRUMENTATION; MECHANICAL STRESS; METHODOLOGY; PHYSIOLOGY; PRESSURE TRANSDUCER; SPECIES DIFFERENCE;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BIOMECHANICS; CENTRAL NERVOUS SYSTEM STIMULANTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; LOCOMOTION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; SPECIES SPECIFICITY; STRESS, MECHANICAL; TRANSDUCERS, PRESSURE;

EID: 33746391589     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2005.10.002     Document Type: Article

References (28)

1. Colpaert F.C., Wauquier A., Niemegeers C., and Lal H. Reversal by a central antiacetylcholine drug of pimozide-induced inhibition of mouse-jumping in amphetamine-dopa treated mice. J Pharm Pharmacol 27 (1975) 536-537
2. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132 (1997) 107-124
3. Davis W.M., Babbini M., Pong S.F., King W.T., and White C.L. Motility of mice after amphetamine: effects of strain, aggregation and illumination. Pharmacol Biochem Behav 2 (1974) 803-809
4. Deutsch S.I., and Hitri A. Measurement of an explosive behavior in the mouse, induced by MK-801, a PCP analogue. Clin Neuropharmacol 16 (1993) 251-257
5. Deutsch S.I., Rosse R.B., Paul S.M., Tomasino V., Koetzner L., Morn C.B., et al. 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology 15 (1996) 37-43
6. Deutsch S.I., Rosse R.B., Paul S.M., Riggs R.L., and Mastropaolo J. Inbred mouse strains differ in sensitivity to "popping" behavior elicited by MK-801. Pharmacol Biochem Behav 57 (1997) 315-317
7. Festing M.F., and Fisher E.M. Mighty mice. Nature 404 (2000) 815
8. Fowler S.C. Microbehavioral methods for measuring the motor and associative effects of dopamine receptor antagonists and related drugs in rodents. Psychopharmacology (Berl) 147 (1999) 8-10
9. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., et al. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods 107 (2001) 107-124
10. Fowler S.C., Zarcone T.J., Chen R., Taylor M.D., and Wright D.E. Low grip strength, impaired tongue force and hyperactivity induced by overexpression of neurotrophin-3 in mouse skeletal muscle. Int J Dev Neurosci 20 (2002) 303-308
11. Fowler S.C., Zarcone T.J., Vorontsova E., and Chen R. Motor and associative deficits in D2 dopamine receptor knockout mice. Int J Dev Neurosci 20 (2002) 309-321
12. Fowler S.C., Birkestrand B., Chen R., Vorontsova E., and Zarcone T. Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies. Psychopharmacology (Berl) 170 (2003) 167-177
13. Fowler S.C., McKerchar T.L., and Zarcone T.J. Response dynamics: measurement of the force and rhythm of motor responses in laboratory animals. In: LeDoux M. (Ed). Animal models of movement disorders (2005), Elsevier Academic Press, Amsterdam 73-100
14. Furukawa T., Ushizima I., and Ono N. Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine. Psychopharmacologia 42 (1975) 243-248
15. Iwamoto E.T., Ho I.K., and Way E.L. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats. J Pharmacol Exp Ther 187 (1973) 567-588
16. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A., and Mogil J.S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115 (2002) 463-469
17. Lal H., Colpaert F.C., and Laduron P. Narcotic withdrawal like mouse jumping produced by amphetamine and l-DOPA. Eur J Pharmacol 30 (1975) 113-116
18. Lal H., Marky M., and Fielding S. Effect of neuroleptic drugs on mouse jumping induced by l-DOPA in amphetamine treated mice. Neuropharmacology 15 (1976) 669-671
19. Mastropaolo J., Rosse R.B., and Deutsch S.I. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia. Behav Brain Res 153 (2004) 419-422
20. Rebec G.V., White I.M., and Puotz J.K. Responses of neurons in dorsal striatum during amphetamine-induced focused stereotypy. Psychopharmacology (Berl) 130 (1997) 343-351
21. Rosse R.B., Mastropaolo J., Sussman D.M., Koetzner L., Morn C.B., and Deutsch S.I. Computerized measurement of MK-801-elicited popping and hyperactivity in mice. Clin Neuropharmacol 18 (1995) 448-457
22. Saelens J.K., Granat F.R., and Sawyer W.K. The mouse jumping test-a simple screening method to estimate the physical dependence capacity of analgesics. Arch Int Pharmacodyn Ther 190 (1971) 213-218
23. Servatius R.J., Ottenweller J.E., Beldowicz D., Guo W., Zhu G., and Natelson B.H. Persistently exaggerated startle responses in rats treated with pyridostigmine bromide. J Pharmacol Exp Ther 287 (1998) 1020-1028
24. van den Buuse M., Morris M., Chavez C., Martin S., and Wang J. Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice. Br J Pharmacol 142 (2004) 543-550
25. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 99-120
26. Wagner G.C., Avena N., Kita T., Nakashima T., Fisher H., and Halladay A.K. Risperidone reduction of amphetamine-induced self-injurious behavior in mice. Neuropharmacology 46 (2004) 700-708
27. Wang G., and Fowler S.C. Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine. Psychopharmacology (Berl) 158 (2001) 273-280
28. Weissman A. Jumping in mice elicited by -naphthyloxy-acetic acid (-NOAA). J Pharmacol Exp Ther 184 (1973) 11-17